GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

EME · Mar 31, 2022

EMCOR Group, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000105634-22-000013General Corporate
Capex intensity40thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.44% · OPTIONAL · VALID

Operating cash generation5thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-3.70% · OPTIONAL · VALID

Revenue growth68thOwn-history percentile · N=19
Evidence method

Yoy · gp.fundamentals.revenue

12.52% · CORE · VALID

Gross margin0thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

13.60% · CORE · VALID

Operating margin10thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

3.86% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History41 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.37%
Current
0.44%
Delta
0.08%
Cash Generation Decreased
Previous
3.22%
Current
-3.70%
Delta
-6.91%
Growth Decreased
Previous
12.58%
Current
12.52%
Delta
-0.06%
Margin Decreased
Previous
15.16%
Current
13.60%
Delta
-1.56%
Profitability Decreased
Previous
5.36%
Current
3.86%
Delta
-1.50%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.